Jauculan, Rose Mae L.
HRN: 27-17-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/21/2025
05/27/2025
IV
600 Mg
Q8h
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes